News Results
There are 370,404 News Results
Feb 27, 2024
-- Focus on clinical stage AAV Therapeutic product candidates addressing large commercial opportunities and value generation -- Prioritized pipeline is expected to further progress to pivotal stage and first BLA...
Feb 27, 2024
SAN JOSE, Calif., Feb. 27, 2024 /PRNewswire/ -- QuickLogic Corporation (NASDAQ: QUIK) ("QuickLogic" or the "Company"), a developer of embedded FPGA (eFPGA) IP, ruggedized FPGAs and Endpoint AI solutions, today...
Feb 28, 2024
-- Expands Viatris' Portfolio of Innovative Assets by Immediately Adding Two Phase 3 Assets, Selatogrel and Cenerimod, Both With Blockbuster Revenue Potential -- Includes Future Optionality to Expand Collaboration With...
Feb 28, 2024
-- Full year 2023 revenues of approximately $21M exceeded guidance with year-over-year growth of 246% -- Q4 2023 revenues of approximately $15M exceeded guidance with 328% growth quarter-over-quarter and 846%...
Feb 29, 2024
Dividend Policy increased by 60% to $8 million per quarter; Company introduces full year 2024 EBITDA guidance of $90-95m and a target to surpass $100m in EBITDA in 2025
Feb 29, 2024
Announced corporate name change to Spyre Therapeutics; appointment of Cameron Turtle, DPhil, as Chief Executive Officer; and began trading on Nasdaq under the symbol "SYRE"
Mar 8, 2024
-- Wegovy(®) (semaglutide) injection 2.4 mg is the first-and-only medicine indicated for both reduction of the risk of major adverse cardiovascular events (MACE) such as death, heart attack, or stroke...
Mar 14, 2024
Company to host conference call and webcast today at 8:30 a.m. EDT
Mar 14, 2024
-- Shareholders are encouraged to vote well in advance of the proxy voting deadline on April 10, 2024 at 1:00 p.m. Eastern Time (Toronto time) -- For any questions or...
Mar 14, 2024
-- Recently announced agreement to divest assets and business operations in China marks an important milestone for the Company; the transaction is expected to close by the end of March...
